Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05077124 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Safe and Timely Antithrombotic Removal (STAR) Registry

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated July 16, 2025 (before its estimated September 30, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Site contacts updated at 1 of 30 sites
    • Publications: details revised at 1 of 4 entries
    v43
  2. Study sites: 29 to 30v42
  3. Site details revised at 1 of 29 sitesv41
  4. Study sites: 27 to 29
    • Publications: details revised at 1 of 4 entries
    v40
  5. Site details revised at 1 of 27 sitesv39
Show 37 earlier versionsHide 37 earlier versions
  1. Study sites: 25 to 27v38
  2. Site contacts updated at 25 of 25 sites
    • Publications: details revised at 1 of 4 entries
    v37
  3. Site details revised at 25 of 25 sites
    • Publications: details revised at 1 of 4 entries
    v36
  4. Enrollment target: 500 to 1000v35
  5. Study sites: 24 to 25v34
  6. Study sites: 23 to 24v33
  7. Site details revised at 2 of 23 sitesv32
  8. Study sites: 21 to 23v31
  9. Site details revised at 2 of 21 sitesv30
  10. Study sites: 20 to 21v29
  11. Site details revised at 1 of 20 sitesv28
  12. Study sites: 19 to 20v27
  13. Site details revised at 1 of 19 sitesv26
  14. Study sites: 18 to 19v25
  15. Site details revised at 1 of 18 sitesv24
  16. Study sites: 17 to 18v23
  17. Site details revised at 1 of 17 sitesv22
  18. Study sites: 15 to 17v21
  19. Study sites: 13 to 15v20
  20. Study sites: 12 to 13v19
  21. Study sites: 11 to 12v18
  22. Site details revised at 1 of 11 sitesv17
  23. Study sites: 9 to 11v16
  24. Site details revised at 2 of 9 sitesv15
  25. Site contacts updated at 1 of 9 sitesv14
  26. Re-verified, no change to tracked fieldsv13
  27. Study sites: 8 to 9v12
  28. Study sites: 7 to 8v11
  29. Site details revised at 1 of 7 sitesv10
  30. Site details revised at 1 of 7 sitesv9
  31. Site details revised at 1 of 7 sitesv8
  32. Study sites: 6 to 7v7
  33. Site details revised at 1 of 6 sitesv6
  34. Study sites: 5 to 6v5
  35. Study sites: 3 to 5v4
  36. Site details revised at 1 of 3 sitesv3
  37. Study sites: 1 to 3v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This registry will capture real-world clinical use patterns and associated clinical outcomes with the use of CytoSorb for the removal of antithrombotic agents.
Trial Details
NCT Number NCT05077124
Lead Sponsor CytoSorbents, Inc
Conditions
(from sponsor)		 Hemorrhage, Surgical, Hemorrhage Postoperative, Blood Loss, Surgical, Blood Loss, Postoperative
Related terms Blood Loss, Surgical, Postoperative Hemorrhage
Enrollment 1,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov